BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7107045)

  • 1. CAPD plus hemoperfusion once a week for end stage renal disease.
    Capodicasa G; De Santo NG; Galione A; Bellavia C; Annaloro R; Vaccaro F; Picone F; Vinti V; Davi G; Rapisarda LM; Giordano C
    Int J Artif Organs; 1982 May; 5(3):125-9. PubMed ID: 7107045
    [No Abstract]   [Full Text] [Related]  

  • 2. CAPD + hemoperfusion once a week in the management of children with end-stage renal disease.
    Capodicasa G; De Santo NG; Vaccaro F; Manzo M; Maione S; Capasso G; Giordano C
    Int J Artif Organs; 1983 Sep; 6(5):241-5. PubMed ID: 6642721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New prescription of peritoneal dialysis: intermittent ambulatory peritoneal dialysis.
    Okada K; Urae J; Takahashi S
    Nephron; 1996; 74(2):459-61. PubMed ID: 8893188
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemosorption in the therapeutic complex for renal insufficiency in children].
    Isakov IuF; Burkov IV; Drozdov VA; Mosharov OP; Osipov IuN
    Urol Nefrol (Mosk); 1980; (5):55-9. PubMed ID: 7423691
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia.
    Stefoni S; Feliciangeli G; Coli L; Scolari MP; Bonomini V
    Int J Artif Organs; 1981 Jul; 4(4):186-91. PubMed ID: 7327760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charcoal hemoperfusion for chronic renal failure.
    Siemsen AW; Dunea G; Mamdani BH; Guruprakash G
    Nephron; 1978; 22(4-6):386-90. PubMed ID: 740102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of CAPD and PD-plus effectiveness.
    Iles-Smith H; Curwell J; Gokal R
    EDTNA ERCA J; 1999; 25(3):27-9. PubMed ID: 10786491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of cimetidine by peritoneal dialysis, hemodialysis, and charcoal hemoperfusion.
    Pizzella KM; Moore MC; Schultz RW; Walshe J; Schentag JJ
    Ther Drug Monit; 1980; 2(3):273-81. PubMed ID: 7222181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum oxalate in chronic renal failure.
    Borland WW; Payton CD; Simpson K; Macdougall AI
    Nephron; 1987; 45(2):119-21. PubMed ID: 3561621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Continuous ambulatory peritoneal dialysis (CAPD)].
    Mydlík M; Derzsiová K; Válek A; Takác M
    Vnitr Lek; 1982 Jun; 28(6):602-8. PubMed ID: 7112984
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary experience with continuous ambulatory peritoneal dialysis.
    Rahman M; Haq SA; Haq A
    Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):52-8. PubMed ID: 7184498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemoperfusion in the treatment of chronic renal failure in patients on haemodialysis.
    Ryabov SI; Shostka GD; Lukichev BG; Strelko VV; Spiridonov VN; Kartel NT; Scherbitsky AB
    Int Urol Nephrol; 1984; 16(4):345-60. PubMed ID: 6535783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamins and continuous ambulatory peritoneal dialysis (CAPD)].
    Mydlík M; Derzsiová K; Válek A; Szabó T; Dandár V; Takác M
    Cas Lek Cesk; 1983 Aug; 122(34):1046-9. PubMed ID: 6627319
    [No Abstract]   [Full Text] [Related]  

  • 14. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
    Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal membrane characteristics in patients on peritoneal dialysis.
    Al-wakeel J; Al-Ghonaim M; Al-Suwaida A; Askar A; Usama S; Feraz N; Shah IH; Memon N; Qudsi A; Sulaimani F
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):49-53. PubMed ID: 21196612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
    Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE
    Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous ambulatory peritoneal dialysis (CAPD) in diabetics with end-stage renal disease.
    Amair P; Khanna R; Digenis G; Oreopoulos DG
    Int J Artif Organs; 1982 Mar; 5(2):81-2. PubMed ID: 7047411
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical assessment of CAPD (continuous ambulatory peritoneal dialysis) for chronic end-stage renal failure].
    Ohira S; Abe K; Kon T
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):478-87. PubMed ID: 6386640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous ambulatory peritoneal dialysis (CAPD) in children.
    Potter DE; McDaid TK; McHenry K; Mar H
    Trans Am Soc Artif Intern Organs; 1981; 27():64-7. PubMed ID: 7331148
    [No Abstract]   [Full Text] [Related]  

  • 20. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.